Gaurav Maini
Stock Analyst at LifeSci Capital
(0.09)
# 4,846
Out of 5,152 analysts
53
Total ratings
11.1%
Success rate
-32.9%
Average return
Main Sectors:
Stocks Rated by Gaurav Maini
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| COAG Hemab Therapeutics Holdings | Initiated Coverage: Buy | $65 | $39.06 | +66.41% | 1 | Nov 9, 2026 | |
| LQDA Liquidia | Upgraded: Buy | $59 | $56.73 | +4.00% | 8 | Oct 14, 2026 | |
| CTNM Contineum Therapeutics | Reiterated: Buy | $23 | $9.55 | +140.84% | 4 | Sep 29, 2026 | |
| TECX Tectonic Therapeutic | Reiterated: Buy | $88 | $20.08 | +338.25% | 10 | Sep 29, 2026 | |
| SION Sionna Therapeutics | Reiterated: Hold | $6 | $3.07 | +95.44% | 14 | Sep 19, 2026 | |
| IKT Inhibikase Therapeutics | Reiterated: Buy | $5 | $1.38 | +262.32% | 6 | Sep 15, 2026 | |
| TENX Tenax Therapeutics | Reiterated: Buy | $35 → $5 | $1.42 | +252.11% | 9 | Aug 10, 2026 | |
| CNTM ConnectM Technology Solutions, Inc. | Initiated Coverage: Buy | $24 | $4.58 | +424.02% | 1 | Jul 30, 2026 |
Hemab Therapeutics Holdings
Nov 9, 2026
Initiated Coverage: Buy
Price Target: $65
Current: $39.06
Upside: +66.41%
Liquidia
Oct 14, 2026
Upgraded: Buy
Price Target: $59
Current: $56.73
Upside: +4.00%
Contineum Therapeutics
Sep 29, 2026
Reiterated: Buy
Price Target: $23
Current: $9.55
Upside: +140.84%
Tectonic Therapeutic
Sep 29, 2026
Reiterated: Buy
Price Target: $88
Current: $20.08
Upside: +338.25%
Sionna Therapeutics
Sep 19, 2026
Reiterated: Hold
Price Target: $6
Current: $3.07
Upside: +95.44%
Inhibikase Therapeutics
Sep 15, 2026
Reiterated: Buy
Price Target: $5
Current: $1.38
Upside: +262.32%
Tenax Therapeutics
Aug 10, 2026
Reiterated: Buy
Price Target: $35 → $5
Current: $1.42
Upside: +252.11%
ConnectM Technology Solutions, Inc.
Jul 30, 2026
Initiated Coverage: Buy
Price Target: $24
Current: $4.58
Upside: +424.02%